Leukine recall – pro
LEUKINE has been FDA approved for use in multiple indications: For use following induction chemotherapy in older adults with Acute Myelogenous Leukemia (AML) For use in myeloid reconstitution after autologous bone marrow transplantation For use in myeloid reconstitution after allogeneic bone marrow transplantation For use in transplantation (BMT) failure or engraftment delay For use in mobilization and following transplantation of autologous peripheral
Read more